- Home
- IGC vs ZYXI Comparison
IGC vs ZYXI Comparison
Compare IGC & ZYXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IGC
- ZYXI
- Stock Information
- Founded
- IGC 2005
- ZYXI 1996
- Country
- IGC United States
- ZYXI United States
- Employees
- IGC N/A
- ZYXI N/A
- Industry
- IGC Biotechnology: Pharmaceutical Preparations
- ZYXI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- IGC Health Care
- ZYXI Health Care
- Exchange
- IGC Nasdaq
- ZYXI Nasdaq
- Market Cap
- IGC 39.8M
- ZYXI 44.8M
- IPO Year
- IGC N/A
- ZYXI N/A
- Fundamental
- Price
- IGC $0.40
- ZYXI $1.32
- Analyst Decision
- IGC Strong Buy
- ZYXI Hold
- Analyst Count
- IGC 2
- ZYXI 3
- Target Price
- IGC $4.00
- ZYXI $3.00
- AVG Volume (30 Days)
- IGC 886.9K
- ZYXI 75.2K
- Earning Date
- IGC 11-14-2025
- ZYXI 10-30-2025
- Dividend Yield
- IGC N/A
- ZYXI N/A
- EPS Growth
- IGC N/A
- ZYXI N/A
- EPS
- IGC N/A
- ZYXI N/A
- Revenue
- IGC $1,327,000.00
- ZYXI $144,808,000.00
- Revenue This Year
- IGC $3.54
- ZYXI N/A
- Revenue Next Year
- IGC $15.12
- ZYXI $7.07
- P/E Ratio
- IGC N/A
- ZYXI N/A
- Revenue Growth
- IGC 24.95
- ZYXI N/A
- 52 Week Low
- IGC $0.25
- ZYXI $1.23
- 52 Week High
- IGC $0.50
- ZYXI $9.33
- Technical
- Relative Strength Index (RSI)
- IGC 46.88
- ZYXI 40.91
- Support Level
- IGC $0.36
- ZYXI $1.30
- Resistance Level
- IGC $0.43
- ZYXI $1.43
- Average True Range (ATR)
- IGC 0.02
- ZYXI 0.07
- MACD
- IGC 0.00
- ZYXI 0.00
- Stochastic Oscillator
- IGC 46.64
- ZYXI 17.65
About IGC IGC Pharma Inc.
IGC Pharma Inc develops cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome, and chronic pain. The company has investigational drug assets targeting Alzheimer's disease, IGC-AD1, IGC-M3, IGC-1C, and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles.
About ZYXI Zynex Inc.
Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufactures, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company operates business as one operating segment which includes two revenue types: Devices and Supplies. Its markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave, and others.